10 NORTH HIGH STREET, WEST CHESTER, PA
Reports Fourth Quarter and Full Year 2025 Financial Results
Appointment of Charles Frantzreb as Director of Verrica Pharmaceuticals
Announces Private Placement Financing of $50 Million to Retire Debt and Extend Cash Runway
Financial Results, Press Release
Earnings Release
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
News, Articles of Incorporation
Announces Amendment to Collaboration and License Agreement to Launch Global Pivotal Phase 3 Clinical Trial to Study YCANTH® for the Treatment of Common Warts
FY 2025
Q3
Q2
Q1
FY 2024
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities Offered under a Shelf Registration
Notice of Exempt Offering of Securities
Registration Statement for Securities to be Offered to Employees
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Amended Schedule 13G - Ownership Report
Amended Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
Statement of Changes in Beneficial Ownership
Amended Schedule 13D - Ownership Report
Definitive Revised Proxy Statement
Correspondence
Submission Upload